NCT06797362
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06797362
Title Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC (NVL-520-EAP)
Acronym NVL-520-EAP
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Nuvalent Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
University of Colorado Anschutz School of Medicine AVAILABLE Aurora Colorado 80045 United States Details
University of Chicago Medical Center AVAILABLE Chicago Illinois 60637 United States Details
Massachusetts General Hospital AVAILABLE Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute AVAILABLE Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center AVAILABLE Manhattan New York 10065 United States Details
Fox Chase Cancer Center AVAILABLE Philadelphia Pennsylvania 19111 United States Details
University of Washington / Fred Hutchinson Cancer Center AVAILABLE Seattle Washington 98109 United States Details
Chris O'Brien Lifehouse AVAILABLE Camperdown New South Wales 2050 Australia Details
Peter MacCallum Cancer Centre AVAILABLE Melbourne Victoria 3000 Australia Details
Cross Cancer Institute AVAILABLE Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Hospital AVAILABLE Toronto Ontario M5G 2M9 Canada Details
Centre Leon Berard AVAILABLE Lyon Auvergne-Rhône-Alpes 69008 France Details
GCS IUCT Oncopole AVAILABLE Toulouse Occitanie 31059 France Details
CHU de Nantes AVAILABLE Nantes Pays de la Loire Region 44800 France Details
Institut Gustave Roussy AVAILABLE Villejuif Île-de-France Region 94800 France Details
IRCCS Istituto Tumori Giovanni Paolo II AVAILABLE Bari 70124 Italy Details
L'Istituto Europeo di Oncologia S.r.l. AVAILABLE Milan 20141 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori AVAILABLE Milan 20133 Italy Details
IRCCS Istituto Oncologico Veneto AVAILABLE Padua 35128 Italy Details
AUSL della Romagna - Ravenna AVAILABLE Ravenna 48121 Italy Details
Istituto Nazionale Tumori "Regina Elena AVAILABLE Roma 00144 Italy Details
Antoni van Leeuwenhoek Hospital AVAILABLE Amsterdam 1006 BE Netherlands Details
Netherlands Cancer Institute: NKI AVAILABLE Amsterdam 1066 CX Netherlands Details
University Medical Center Groningen AVAILABLE Groningen 9713 GZ Netherlands Details
National University Hospital Singapore AVAILABLE Singapore 119074 Singapore Details
National Cancer Centre Singapore AVAILABLE Singapore 168583 Singapore Details
Uomi Cancer Center-Clinica Tres Torres AVAILABLE Barcelona 08017 Spain Details
Hospital Universitario Vall d'Hebron AVAILABLE Barcelona 08035 Spain Details
Gregorio Marañón General University Hospital AVAILABLE Madrid 28007 Spain Details
Hospital Univ Doce de Octubre AVAILABLE Madrid 28041 Spain Details
National Cheng Kung University Hospital AVAILABLE Tainan 70403 Taiwan Details
National Taiwan University Hospital AVAILABLE Taipei 100229 Taiwan Details
The Royal Marsden Hospital AVAILABLE Sutton Surrey SM2 5PT United Kingdom Details
The Royal Marsden Hospital AVAILABLE London SM2 5PT United Kingdom Details
The Christie Hospital AVAILABLE Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field